[1] |
Maxwell RR, Cole PD. Pharmacogenetic predictors of treatment-related toxicity among children with acute lymphoblastic leukemia[J]. Curr Hematol Malig Rep, 2017, 12(3):176-186.
doi: 10.1007/s11899-017-0376-z
|
[2] |
Tang JH, Tian JM, Sheng M, et al. Study of posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia after induction chemotherapy[J]. J Child Neurol, 2016, 31(3):279-284.
doi: 10.1177/0883073815589758
|
[3] |
Maytal J, Grossman R, Yusuf FH, et al. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia[J]. Epilepsia, 1995, 36(8):831-836.
pmid: 7635103
|
[4] |
Goyal M, Bangert BA, Wiznitzer M. Mesial temporal sclerosis in acute childhood leukemias[J]. Epilepsia, 2003, 44(1):131-134.
doi: 10.1046/j.1528-1157.2003.20302.x
|
[5] |
Anastasopoulou S, Heyman M, Eriksson MA, et al. Seizures during treatment of childhood acute lymphoblastic leukemia: a population-based cohort study[J]. Eur J Paediatr Neurol, 2020, 27:72-77.
doi: 10.1016/j.ejpn.2020.04.004
|
[6] |
Rao RD, Swanson JW, Dejesus RS, et al. Methotrexate induced seizures associated with acute reversible magnetic resonance imaging (MRI) changes in a patient with acute lymphoblastic leukemia[J]. Leuk Lymphoma, 2002, 43(6):1333-1336.
doi: 10.1080/10428190290026402
|
[7] |
陈波, 宪莹, 苏庸春, 等. CCLG-ALL 08方案治疗儿童急性淋巴细胞白血病毒副作用的临床研究[J]. 中国当代儿科杂志, 2013, 15(9):737-742.
|
[8] |
许凤玲, 管贤敏, 温贤浩, 等. 儿童急性淋巴细胞白血病化疗相关严重不良反应的临床分析[J]. 中国当代儿科杂志, 2020, 22(8):828-833.
|
[9] |
Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy[J]. Epilepsia, 2014, 55(4):475-482.
doi: 10.1111/epi.12550
|
[10] |
吴立文, 金丽日. 解读新的癫痫临床实用性定义[J]. 中华神经科杂志, 2014, 47(8):513-515.
|
[11] |
Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2010, 10(5):317-328.
doi: 10.1016/S1473-3099(10)70048-7
pmid: 20417414
|
[12] |
Baytan B, Evim MS, Güler S, et al. Acute central nervous system complications in pediatric acute lymphoblastic leukemia[J]. Pediatr Neurol, 2015, 53(4):312-318.
doi: 10.1016/j.pediatrneurol.2015.03.006
pmid: 26202590
|
[13] |
Millan NC, Pastrana A, Guitter MR, et al. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia[J]. Leuk Res, 2018, 65:86-93.
doi: 10.1016/j.leukres.2017.12.010
|
[14] |
Nassar SL, Conklin HM, Zhou Y, et al. Neurocognitive outcomes among children who experienced seizures during treatment for acute lymphoblastic leukemia[J]. Pediatr Blood Cancer, 2017, 64(8):10.
|
[15] |
Andrés-Jensen L, Attarbaschi A, Bardi E, et al. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia[J]. Lancet Haematol, 2021, 8(7):e513-e523.
doi: 10.1016/S2352-3026(21)00136-8
pmid: 34171282
|
[16] |
Parasole R, Petruzziello F, Menna G, et al. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution[J]. Leuk Lymphoma, 2010, 51(6):1063-1071.
doi: 10.3109/10428191003754608
|
[17] |
Hamamoto K, Oriuchi N, Kanazawa T, et al. Mesial temporal sclerosis associated with methotrexate-induced leukoencephalopathy[J]. Pediatr Neurol, 2009, 40(4):306-309.
doi: 10.1016/j.pediatrneurol.2008.10.022
pmid: 19302946
|
[18] |
Hammad MY. Frenkel EP, Bick R. L-asparaginase-provoked seizures as singular expression of central nervous toxicity[J]. Clin Appl Thromb Hemost, 2000, 6(4):234-238.
doi: 10.1177/107602960000600409
|
[19] |
Mahapatra M, Kumar R, Choudhry VP. Seizures as an adverse drug reaction after therapeutic dose of vincristine[J]. Ann Hematol, 2007, 86(2):153-154.
doi: 10.1007/s00277-006-0201-6
|
[20] |
刘素香, 肖佩芳, 胡绍燕, 等. 儿童造血干细胞移植后神经系统并发症的临床分析[J]. 中华器官移植杂志, 2019, 40(11):691-695.
|
[21] |
Antunes NL. Seizures in children with systemic cancer[J]. Pediatr Neurol, 2003, 28(3):190-193.
pmid: 12770671
|
[22] |
Kishi S, Griener J, Cheng C, et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia[J]. J Clin Oncol, 2003, 21(16):3084-3091.
doi: 10.1200/JCO.2003.07.056
|
[23] |
Banerjee JS, Heyman M, Palomäki M, et al. Posterior reversible encephalopathy syndrome: risk factors and impact on the outcome in children with acute lymphoblastic leukemia treated with nordic protocols[J]. J Pediatr Hematol Oncol, 2018, 40(1):e13-e18.
doi: 10.1097/MPH.0000000000001009
|
[24] |
张雷, 吴学东. 儿童急性淋巴细胞白血病合并可逆性后部脑病综合征2例并文献复习[J]. 亚洲儿科病例研究, 2020, 8(2):13-17.
|
[25] |
Anastasopoulou S, Eriksson MA, Heyman M, et al. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: clinical characteristics, risk factors, course, and outcome of disease[J]. Pediatr Blood Cancer, 2019, 66(5):e27594.
doi: 10.1002/pbc.v66.5
|
[26] |
Goldberg-Stern H, Cohen R, Pollak L, et al. The mystery of electroencephalography in acute lymphoblastic leukemia[J]. Seizure, 2011, 20(3):194-196.
doi: 10.1016/j.seizure.2010.11.016
pmid: 21292506
|
[27] |
Guruprasad CS, Binitha R, Nair M, et al. Etiological profile of seizures in children undergoing chemotherapy for acute lymphoblastic leukemia[J]. Pediatr Hematol Oncol J, 2016, 1(2):S12.
|
[28] |
Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics[J]. Clin Ther, 2008, 30(8):1385-1407.
doi: 10.1016/j.clinthera.2008.08.011
|